Peripheral neuropathies and anti-glycolipid antibodies
The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Abstract
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain-Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [990]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998) · Neurology · doi:10.1212/wnl.51.4.1110 · Cited by 826
Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
[10] Gangliosides: Structure, isolation, and analysis
Ledeen, R. W., & Yu, R. K. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)83012-7 · Cited by 701
Cited by
Items 401–500 of 764
Bedeutung intravenöser Immunglobuline zur Behandlung immunvermittelter Polyneuropathien
Stangel, M., Hartung, H., Gold, R., & Kieseier, B. C. (2009) · Der Nervenarzt · doi:10.1007/s00115-008-2631-y · Cited by 13
Anti-glycolipid antibodies in patients with neuropathy: A diagnostic assessment
Johannis, W., Renno, J. H., Klatt, A. R., & Wielckens, K. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.07.041 · Cited by 13
Kazmi, M., Mahdi‐Rogers, M., & Sanvito, L. (2008) · Autoimmunity · doi:10.1080/08916930802198253 · Cited by 13
Assessing the safety of influenza vaccination in specific populations: children and the elderly
Rowhani‐Rahbar, A., Klein, N. P., & Baxter, R. P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.66 · Cited by 13
Halstead, S. K., Gourlay, D., Penderis, J., Bianchi, E., Dondi, M., Wessmann, A., Musteață, M., Chevoir, M. L., Martinez‐Anton, L., Bhatti, S. F. M., et al. (2021) · Journal of Small Animal Practice · doi:10.1111/jsap.13439 · Cited by 12
Self-citationHořejší, K., & Holčapek, M. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05475-7 · Cited by 12
Rapidly Progressive Guillain-Barré Syndrome Following Escherichia coli Infection
Kono, Y., Nishitarumizu, K., Higashi, T., Funakoshi, K., & Odaka, M. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6330 · Cited by 12
Campylobacter jejuni and Postinfectious Autoimmune Diseases: A Proof of Concept in Glycobiology
Stein, R. A. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00397 · Cited by 12
Progress in inflammatory neuropathy —the legacy of Dr Jack Griffin
Feldman, E. L., Hughes, R. A., & Willison, H. J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.192 · Cited by 12
Self-citationAnti-ganglioside antibody-associated acute unilateral peripheral vestibulopathy
Lee, S., Kim, H., Choi, J., & Kim, J. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9109-z · Cited by 12
Fusco, C., Bertani, G., Scarano, A., & Giustina, E. D. (2007) · Journal of Child Neurology · doi:10.1177/0883073807301921 · Cited by 12
Yoshino, H., Ariga, T., Suzuki, A., Yu, R. K., & Miyatake, T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.020 · Cited by 12
Therapy of immune neuropathies with intravenous immunoglobulins
Gold, R., & Kieseier, B. C. (2006) · Journal of Neurology · doi:10.1007/s00415-006-5008-9 · Cited by 12
Siponimod ameliorates experimental autoimmune neuritis
Uchi, T., Konno, S., Kihara, H., & Fujioka, T. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02706-z · Cited by 11
Novel treatment for immune neuropathies on the horizon
Hartung, H., Lehmann, H. C., Kieseier, B. C., & Hughes, R. A. (2011) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2011.00334.x · Cited by 11
Acute/chronic inflammatory polyradiculoneuropathy
Miranda, C., & Brannagan, T. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00026-1 · Cited by 11
Han, Y., Wu, L., Rich, J. R., Huang, F.-T., Withers, S. G., Feng, Y. F., & Yang, G. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6421-8 · Cited by 11
Rabinstein, A. A. (2007) · The Open General & Internal Medicine Journal · doi:10.2174/1874076600701010013 · Cited by 11
Acute motor neuropathy with pure distal involvement – A case report of multifocal motor neuropathy
Ramdas, S., Prasad, M., Spillane, K., & Kirkpatrick, M. (2013) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.12.005 · Cited by 11
Kühle, J., & Petzold, A. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.578624 · Cited by 11
Jung, S., Zimmer, S., Lüneberg, E., Frosch, M., Karch, H., Korn, T., & Toyka, K. V. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.02.028 · Cited by 11
Piao, H. Z., Minohara, M., Kawamura, N., Li, W., Mizunoe, Y., Umehara, F., Goto, Y., Kusunoki, S., Matsushita, T., Ikenaka, K., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.10.007 · Cited by 11
van Doorn, P. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814572-2.00002-9 · Cited by 11
Peillet, C., Adams, D., Attarian, S., Bouhour, F., Cauquil, C. A., Cassereau, J., Chanson, J., Cintas, P., Créange, A., Delmont, É., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15523 · Cited by 10
Andrusiów, S., Pawlak, Z., Stańczykiewicz, B., Bogunia‐Kubik, K., & Koszewicz, M. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114974 · Cited by 10
Antibodies in immune-mediated peripheral neuropathies. Where are we in 2024?
Antoine, J.-C. G. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2024.09.002 · Cited by 10
Franciotta, D. M., Gastaldi, M., Biagioli, T., Benedetti, L., Giannotta, C., Bedin, R., Zardini, E., & Nobile‐Orazio, E. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0234 · Cited by 10
Syndrome de Guillain-Barré : physiopathologie et aspects diagnostiques
Carpentier, V. T., Guennec, L. L., Fall, S. A. A., Viala, K., Demeret, S., & Weiss, N. (2022) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.12.005 · Cited by 10
Brezovska, K., Panovska, A. P., Grozdanova, A., Šuturkova, L., Basta, I. Z., & Apostolski, S. (2011) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.83576 · Cited by 10
Pukin, A. V., Florack, D. E. A., Brochu, D., van Lagen, B., Visser, G. M., Wennekes, T., Gilbert, M., & Zuilhof, H. T. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob00009h · Cited by 10
Detection of antibodies in neuropathy patients by synthetic GM1 mimics
Pukin, A., Jacobs, B. C., Tio‐Gillen, A. P., Gilbert, M., Endtz, H. P., van Belkum, A., Visser, G. M., & Zuilhof, H. T. (2011) · Glycobiology · doi:10.1093/glycob/cwr093 · Cited by 10
Impact social et psychologique des jeux d’argent en ligne chez les jeunes adultes
Lejoyeux, M. (2012) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31872-2 · Cited by 10
Uysalol, M., Tatlı, B., Üzel, N., Çıtak, A., Aygün, E., & Kayaoğlu, S. (2013) · Balkan Medical Journal · doi:10.5152/balkanmedj.2013.8334 · Cited by 10
Guillain–Barré syndrome and its treatment
Douglas, M. R., & Winer, J. B. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.10.1569 · Cited by 10
Serum antibodies targeting neurons of the monoaminergic systems in Guillain-Barré syndrome
Rink, C., Görtzen, A., Veh, R. W., & Prüß, H. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.078 · Cited by 10
Autoantobodies activate small GTPase RhoA to modulate neurite outgrowth
Sheikh, K. A. (2011) · Small GTPases · doi:10.4161/sgtp.2.4.17115 · Cited by 10
Cell density-dependent membrane distribution of ganglioside GM3 in melanoma cells
Murate, M., Yokoyama, N., Tomishige, N., Richert, L., Humbert, N., Pollet, B., Makino, A., Kono, N., Mauri, L., Aoki, J., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04813-9 · Cited by 9
Glycoconjugates and Neuroimmunological Diseases
Willison, H. J. (2014) · Advances in neurobiology · doi:10.1007/978-1-4939-1154-7_25 · Cited by 9
Self-citationLawson, V. H., & Robbins, N. M. (2018) · touchREVIEWS in Neurology · doi:10.17925/usn.2018.14.2.102 · Cited by 9
Demyelinating symmetric motor polyneuropathy with high titers of anti‐GM1 antibodies
O’Ferrall, E., White, C. M., & Zochodne, D. W. (2010) · Muscle & Nerve · doi:10.1002/mus.21755 · Cited by 9
Kwon, H., Hong, Y., Sung, J., Paeng, J. C., Lee, D. S., & Lee, K. W. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2005.01.012 · Cited by 9
Harmful effects of anti‐GalNAc‐GD1a antibodies and TNF‐α on rat dorsal root ganglia
Kamakura, K., Kaida, K., Kusunoki, S., Miyamoto, N., Masaki, T., Nakamura, R., Motoyoshi, K., & Fukuda, J. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.0010209.x · Cited by 9
Botulism in pregnancy – a clinical approach to diagnosis and management
Rimawi, B. H. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1457641 · Cited by 9
Use of immunoassays in neurological diagnosis and research
Meriggioli, M. N. (2005) · Neurological Research · doi:10.1179/016164105x49535 · Cited by 9
Young, J. W., Mason, D. F., & Taylor, B. V. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.05.028 · Cited by 9
Rabbit model of Guillain‐Barré syndrome
Nachamkin, I. (2002) · Annals of Neurology · doi:10.1002/ana.10223 · Cited by 9
Multifocal motor neuropathy with and without conduction block: A single entity?
Menkes, D. L. (2007) · Neurology · doi:10.1212/01.wnl.0000261163.44503.08 · Cited by 9
Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies
Chen, J. Y., Sanghani, N., Palmer, K., Li, Y., Lin, F., & Abbatemarco, J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1695461 · Cited by 8
Haq, M. A. U., Nabi, D., Khan, M. O., Ullah, R., Junaid, M., & Nasarullah, H. M. (2023) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v4i03.565 · Cited by 8
Innate immunity in the nervous system
Ramaglia, V., & Baas, F. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17507-6 · Cited by 8
Enteritis caused by Campylobacter jejuni followed by acute motor axonal neuropathy: a case report
Miljković-Selimović, B., Lavrnić, D., Morić, O., Ng, L.-K., Price, L. J., Šuturkova, L., Kocić, B. D., Babić, T., Ristić, L., & Apostolski, S. (2010) · Journal of Medical Case Reports · doi:10.1186/1752-1947-4-101 · Cited by 8
Autoimmune peripheral neuropathies
Dalakas, M. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04404-2.10066-1 · Cited by 8
Neuromuscular Disease A Case-Based Approach
Wokke, J. H. J., van Doorn, P. A., Hoogendijk, J. E., & de Visser, M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511735905 · Cited by 8
van Schaik, I. N., Léger, J., Nobile‐Orazio, E., Cornblath, D. R., Hadden, R. D. M., Koski, C. L., Pollard, J., Sommer, C., Illa, I., den Bergh, P. Y. K. V., et al. (2010) · Wiley eBooks · doi:10.1002/9781444328394.ch21 · Cited by 8
Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy
Lehmann, H. C., Hoffmann, F. R., zu Hörste, G. M., Hartung, H. ‐., & Kieseier, B. C. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02977.x · Cited by 8
Taylor, B. V., Williamson, J., Jones, D., Coleman, D., Luck, J., & McGregor, A. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2006.01.040 · Cited by 8
Analysis of humoral immune responses to LM1 ganglioside in guinea pigs
Gu, Y., Chen, Z.-W., Siegel, A., Koshy, R., Ramirez, C., Raabe, T. D., DeVries, G. H., & Ilyas, A. A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.001 · Cited by 8
Neuropathie motrice multifocale avec blocs de conduction persistants
Léger, J., & Vargas, S. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74669-3 · Cited by 8
Dixièmes Journées des Maladies du Système Nerveux Périphérique
Küntzer, T. (2006) · Revue Neurologique · doi:10.1016/s0035-3787(06)75144-x · Cited by 8
Multifocal Motor Neuropathy and Conduction Block
Taylor, B. V., & Willison, H. J. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50104-6 · Cited by 8
Self-citationInfluence of impaired T‐ and B‐cell compartments on efficacy of IVIg in dysimmune neuropathies
Matà, S., Corzani, S., Biagiotti, R., Piacentini, S., Siracusa, G., Giudizi, M. G., Mastio, M. D., Borsini, W., Taiuti, R., Vultaggio, A., et al. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01929.x · Cited by 8
Mazzoleni, A., Mallet, J., Rovero, P., & Papini, A. M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.12.030 · Cited by 8
Basic and clinical aspects of autoimmune disorders in peripheral nerves
Willison, H. J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00607.x · Cited by 8
Self-citationCai, Z., Blumbergs, P. C., Koblar, S. A., Cash, K., Manavis, J., Ghabriel, M. N., & Thompson, P. D. (2004) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2004.009206.x · Cited by 8
Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS neurologic diseases
Stathopoulos, P., & Dalakas, M. C. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00003-1 · Cited by 7
Blank, M., Krause, I., Dotan, N., Anafi, L., Eisenstein, M., Cervera, R., Meroni, P. L., & Shoenfeld, Y. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.07.002 · Cited by 7
Chi, M., Han, L., & Zhu, Z. (2023) · Journal of International Medical Research · doi:10.1177/03000605231189114 · Cited by 7
Survival of Campylobacter jejuni in chicken meat at frozen storage temperatures
Ivić-Kolevska, S., Miljković-Selimović, B., & Kocić, B. D. (2012) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.59.2012.2.4 · Cited by 7
Autoimmune inflammatory neuropathies: updates in pathogenesis, diagnosis, and treatment
Wong, H. Y., & Yuki, N. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000242 · Cited by 7
Diagnostics of dysimmune peripheral neuropathies
Franciotta, D. M., Gastaldi, M., Benedetti, L., Pesce, G., Biagioli, T., Lolli, F., Costa, G., Melis, C., Andreetta, F., Simoncini, O., et al. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3025-3 · Cited by 7
Guillain-Barré and Miller Fisher Overlap Syndrome Mimicking Alimentary Botulism
Legast, G. M., Lascano, A. M., Gschwind, M., Schnider, A., & Nicastro, N. (2017) · Journal of Clinical Neurology · doi:10.3988/jcn.2017.13.4.442 · Cited by 7
Yang, M. C., & Liu, A. K. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3132 · Cited by 7
A 50-Year-Old Patient with Guillain–Barré Syndrome after COVID-19: A Case Report
Chmiela, T., Rzepka, M., Krzystanek, E., & Gorzkowska, A. (2021) · Medicina · doi:10.3390/medicina57080775 · Cited by 7
Methods for Assessing Neurotoxicity in Zebrafish
Li, C., Seng, W. L., Park, D., & McGrath, P. (2011) · Wiley eBooks · doi:10.1002/9781118102138.ch10 · Cited by 7
Hegen, H., Wanschitz, J., Ehling, R., Deisenhammer, F., Löscher, W. N., Reindl, M., & Berger, T. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00264.x · Cited by 7
Kim, S., Kim, J. K., & Suh, C. K. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.02.035 · Cited by 7
Ataxias related to sensory neuropathies
Riggins, S., & England, J. D. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-51892-7.00043-7 · Cited by 7
Genetically Engineered Probiotics: A New Twist on an Old Remedy
Taylor, C. P., & LaMont, J. T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.052 · Cited by 7
Ganglioside complexes as target antigens in Guillain–Barré syndrome and related disorders
Kaida, K., & Kusunoki, S. (2008) · Future Lipidology · doi:10.2217/17460875.3.4.425 · Cited by 7
Is serum bilirubin associated with the severity of Guillain–Barré syndrome?
Li, X., Li, W., Shi, X., Mo, L., Luo, Y., Qin, L., Yang, Z., & Mo, W. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1404465 · Cited by 7
Ruggiero, F. M., Vilcaes, A. A., Yuki, N., & Daniotti, J. L. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.10.020 · Cited by 6
Sakai, T., Kondo, M., Tomimoto, H., & Yamagishi, Y. (2016) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-000887 · Cited by 6
Multifocal motor neuropathy presenting as a post-infectious complication of dengue: a CASE report
Higgoda, R., Perera, D., & Thirumavalavan, K. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3334-z · Cited by 6
McGonigal, R., Barrie, J. A., Yao, D., Black, L. E., McLaughlin, M., & Willison, H. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15365 · Cited by 6
Self-citationJacob-Lebas, M., & Vignal‐Clermont, C. (2011) · Encyclopédie médico-chirurgicale. Ophtalmologie · doi:10.1016/s0246-0343(11)45505-2 · Cited by 6
Martínez‐Martínez, L., Lacruz, A. C., Querol, L., Cortés‐Vicente, E., Pascual‐Goñi, E., Rojas‐García, R., Reyes‐Leiva, D., Gargallo, Y. Á., Moltó, E., Ortiz, E., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12317-0 · Cited by 6
A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples
Usuki, S., O'Brien, D. K., Rivner, M. H., & Yu, R. K. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.05.005 · Cited by 6
Variants of Guillain-Barré syndrome: low incidence but high impact
Lehmann, H. C., & Hartung, H. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5253-9 · Cited by 6
Persistent multifocal conduction block in vasculitic neuropathy with IgM anti‐gangliosides
Notturno, F., Caporale, C. M., Muzio, A. D., & Uncini, A. (2007) · Muscle & Nerve · doi:10.1002/mus.20778 · Cited by 6
Node of Ranvier disruption in Guillain–Barré syndrome
Susuki, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12338 · Cited by 6
Lardone, R. D., Irazoqui, F. J., & Nores, G. A. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0562-5 · Cited by 6
Halstead, S. K., Jackson, M. R., Bianchi, E., Rupp, S., Granger, N. P., Menchetti, M., Galli, G., Freeman, P., Kaczmarska, A., Bhatti, S. F. M., et al. (2022) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12529 · Cited by 6
Self-citationDiagnostic value of anti-GQ1b antibodies in a patient with relapsing dysarthria and ataxia
Kuijf, M. L., Ruts, L., van Doorn, P. A., Koudstaal, P. J., & Jacobs, B. C. (2009) · BMJ Case Reports · doi:10.1136/bcr.08.2008.0783 · Cited by 6
Hayashi, T., Nukui, T., Takashima, S., Nakatsuji, Y., Shima, S., & Mutoh, T. (2018) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001131 · Cited by 6
Sakumoto, Y., Ueta, H., Yuki, N., & Matsuno, K. (2009) · Archivum histologicum japonicum · doi:10.1679/aohc.72.77 · Cited by 6
Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain–Barré syndrome
van Sorge, N. M., Yuki, N., Koga, M., Susuki, K., Jansen, M., van Kooten, C., Wokke, J. H. J., van de Winkel, J. G. J., van der Pol, W. L., & van den Berg, L. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.015 · Cited by 6
Plasmaaustausch als Therapieoption bei neurologischen Erkrankungen
Lehmann, H. C., Hartung, H.-P., Hetzel, G. R., & Kieseier, B. C. (2007) · Der Nervenarzt · doi:10.1007/s00115-006-2229-1 · Cited by 6
Willison, H. J., Gregson, N. A., O’Hanlon, G. M., & Hughes, R. A. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50029-6 · Cited by 6
Self-citationMyelin Lipids and Proteins: Structure, Function, and Roles in Neurological Disorders
Quarles, R. H. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn065 · Cited by 6
Hadhiah, K. M., Alhashim, A., Al-Dandan, H. A., Alhassan, E., Alqarni, A. M., Memish, A. A. A., & Alabdali, M. M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1332364 · Cited by 5
Metadata
- Authors
- Willison, H. J.
- Affiliations
- Southern General Hospital (GB)
- Corresponding author
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 125
- Issue
- 12
- Pages
- 2591-2625
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021949020
- Cited by
- 710
- References
- 286
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 12 · 2018: 20 · 2017: 23 · 2016: 34 · 2015: 30 · 2014: 37 · 2013: 32 · 2012: 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- anti-glycolipid antibodies, peripheral neuropathy, Guillain-Barré syndrome, Miller Fisher syndrome, acute motor axonal neuropathy, gangliosides, GM1, GD1a, GQ1b, Campylobacter jejuni, molecular mimicry, sensory neuropathy, immunomodulatory therapy
- MeSH terms
- Animals, Autoantibodies, Glycolipids, Humans, Immunoglobulin G, Immunoglobulin M, Peripheral Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.